Fosaprepitant , Tropisetron and Olanzapine for the Prevention of Nausea and Vomiting in Patients With Breast Cancer
Condition(s):Chemotherapy-induced Nausea and VomitingLast Updated:February 26, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Chemotherapy-induced Nausea and VomitingLast Updated:February 26, 2024Completed
Condition(s):Bipolar DepressionLast Updated:July 31, 2017Completed
Condition(s):HealthyLast Updated:November 27, 2013Completed
Condition(s):HealthyLast Updated:October 25, 2017Completed
Condition(s):Borderline Personality DisorderLast Updated:July 24, 2006Completed
Condition(s):Bipolar I DisorderLast Updated:June 3, 2009Completed
Condition(s):Immunoassay; AntipsychoticLast Updated:April 18, 2018Completed
Condition(s):Schizophrenic DisordersLast Updated:June 22, 2007Completed
Condition(s):Neuroleptic-Induced Tardive DyskinesiaLast Updated:February 22, 2008Completed
Condition(s):Hematopoietic/Lymphoid Cancer; Pain; Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:March 9, 2012Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.